MMP2 also plays a crucial role in epigenetic modifications related to AD by facilitating myogenic gene activation and Aβ degradation [25], as demonstrated by the effects of novel HDAC inhibitors that target MMP2 activity [32]. This evidence concerns the gene MMP2 and Alzheimer disease.